LINDSAY JESSUP: Open Payments
NPI 1588186688 · DRESDEN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 11 payments from 8 companies in 2025. Trend: 2023 $390 · 2024 $105 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| ABIOMED | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| CVRx, Inc. | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
Products named: REPATHA, LEQVIO, UPTRAVI, NEXLETOL, Wegovy, Barostim Neo System, WATCHMAN FLX.
Industry payments across OH — which companies pay providers there.
